Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Baird Medical Investment Holdings (BDMD) Assets (2023 - 2025)

Historic Assets for Baird Medical Investment Holdings (BDMD) over the last 3 years, with Q2 2025 value amounting to $77.0 million.

  • Baird Medical Investment Holdings' Assets changed N/A to $77.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $77.0 million, marking a year-over-year change of. This contributed to the annual value of $78.0 million for FY2024, which is 3748.03% up from last year.
  • Latest data reveals that Baird Medical Investment Holdings reported Assets of $77.0 million as of Q2 2025.
  • Baird Medical Investment Holdings' Assets' 5-year high stood at $78.0 million during Q4 2024, with a 5-year trough of $56.7 million in Q4 2023.
  • In the last 3 years, Baird Medical Investment Holdings' Assets had a median value of $77.0 million in 2025 and averaged $70.6 million.
  • Data for Baird Medical Investment Holdings' Assets shows a peak YoY increase of 3748.03% (in 2024) and a maximum YoY decrease of 3748.03% (in 2024) over the last 5 years.
  • Baird Medical Investment Holdings' Assets (Quarter) stood at $56.7 million in 2023, then surged by 37.48% to $78.0 million in 2024, then dropped by 1.25% to $77.0 million in 2025.
  • Its Assets stands at $77.0 million for Q2 2025, versus $78.0 million for Q4 2024 and $56.7 million for Q4 2023.